Smoking cessation improves cardiometabolic risk in overweight and obese subjects treated with varenicline and dietary counseling. [electronic resource]
Producer: 20170829Description: 335-341 p. digitalISSN:- 1590-3729
- Adult
- Biomarkers -- blood
- Blood Pressure
- Counseling
- Female
- Humans
- Insulin Resistance
- Male
- Metabolic Syndrome -- diagnosis
- Middle Aged
- Nicotinic Agonists -- adverse effects
- Norway -- epidemiology
- Obesity -- blood
- Prevalence
- Risk Assessment
- Risk Factors
- Smoking -- adverse effects
- Smoking Cessation -- methods
- Smoking Prevention
- Time Factors
- Treatment Outcome
- Triglycerides -- blood
- Varenicline -- adverse effects
- Weight Loss
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.